News

In this blog, Samuel Omotosho shares his experience working as intern in the Health Data Research programme at Genomics ...
In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, ...
Adam Clatworthy, Vice Chair for Rare Conditions on the Participant Panel for Genomics England, shares the Panel's vision for shaping a future in genomics… ...
What do we mean by no primary findings? Not all genomic tests will result in primary findings or a diagnosis. When no primary findings are found, this means that no genetic changes have been ...
Genomics England researchers have played a key role in the development of a new artificial intelligence tool, known as SAVANA, that uses long-read sequencing data to find specific changes within a ...
In this blog, Clinical Bioinformatician Clare Kennedy shares her experience in clinical bioinformatics and the impact of her work on patient care.
In this blog, Nadezhda Feliz, Genomics Data Scientist, shares her motivation for working in rare conditions research.
At Genomics England, we are committed to transforming health outcomes through innovation in genomics that benefit all patients, regardless of their background. Our Diverse Data Initiative is leading ...
The Generation Study is a research initiative aiming to explore the use of whole genome sequencing in newborns, to screen for more than 200 rare genetic conditions. This study will recruit 100,000 ...
This month Genomics England is marking Sickle Cell Awareness Month, which aims to bring greater visibility of the genetic condition and those affected by it. In recognition of sickle cell’s importance ...
Volunteer recruitment has begun for a new collaborative research programme focused on improving our knowledge and understanding of health conditions and their unique impacts on UK Black communities.
One hundred thousand whole genomes have now been sequenced through the NHS Genomic Medicine Service (NHS GMS) – supported by Genomics England and Illumina - which has led to new diagnoses, more ...